LABORIE is proud to announce their partnership with the Society of Urologic Nurses and Associates (SUNA) to award two annual scholarships to SUNA members for the Comprehensive 2.5 day Urodynamics Course. This course is taught by Dr. Mikel Gray, an expert on the subject of Pelvic Floor Diagnostics as well as the author of the “Traces: Making Sense of Urodynamics Testing” article series.
These scholarships are to be awarded at the two annual meetings hosted by SUNA, each one providing a complimentary registration to an upcoming scheduled 2.5 day course. SUNA has released the following statement: “The SUNA Foundation is most appreciative to have received two Complimentary Registrations for LABORIE’s Urodynamics Course. These awards will be presented annually to SUNA members interested in enhancing their knowledge of Urodynamics. The SUNA Foundation wishes to thank LABORIE and is pleased to award the first LABORIE Scholarship to SUNA member Kristell Lambeck, RN of San Antonio, TX.”
LABORIE would like to congratulate the deserving recipient, Kristell Lambeck, RN! For SUNA members interested in applying for this scholarship, information can be found at www.suna.org (Click on Foundation tab).
LABORIE (www.laborie.com), headquartered in Toronto, Canada, is a leading global developer, manufacturer and marketer of innovative medical technology and consumables used for the diagnosis and treatment of Urinary and Fecal Incontinence, as well as other pelvic floor disorders in the Urology, Gynecology, and Colorectal fields.
LABORIE Medical Technologies (“LABORIE”) and Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”) today announced the completion of the acquisition by LABORIE of Cogentix through LABORIE’S affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”).
LABORIE Medical Technologies (“LABORIE”) announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”) to purchase all outstanding shares of common stock of Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”)
LABORIE Medical Technologies, a leading global developer and manufacturer of medical diagnostics and devices in the pelvic health and gastroenterology market, today announces the execution of a definitive agreement to acquire Cogentix Medical Inc., (NASDAQ: CGNT)